Skip to main content

Upgraded to Windows 10? Try an alternative browser.

browsing on windows 10
An alternative browser

While Windows 10 comes with two of its own internet browsers, Internet Explorer and Microsoft Edge, you may be looking for a new alternative. We'll take you through Opera for Windows 10 in this month's newsletter.
In this edition, we'll also show you how we spent our Nelson Mandela Day.


The Opera Newsletter team
find the best apps
Look for the Top Developer badge.
Read more
secure browsing
Web-browsing tips to protect you online.
Read more
e-learning
Watch how we celebrated Nelson Mandela Day.
Read more
stumbleupon on opera

Social-media extensions add spice to browsing on Opera. Here's a collection of some of our favorites.
Read more
our products
About Opera
Opera products enable more than 350 million internet consumers to discover and connect with the content and services that matter most to them, no matter what device, network or location.
Contact us
http://forums.opera.com Gjerdrums vei 19
NO-0484 OSLO
NORWAY
Social media
© 2015 Opera Software ASA. All Rights Reserved

 
Unsubscribe   /    Send to a friend
 






This email was sent to dbtech.hp.alert@blogger.com
why did I get this?    unsubscribe from this list    update subscription preferences
Opera Software · Gjerdrums vei 19, Oslo, Norway · Oslo, Oslo 0484 · Norway

Comments

Post a Comment

Popular posts from this blog

The first drug for a common, deadly liver disease is here – and more are coming

VIEW IN BROWSER | SUBSCRIBE TUE, MAR 19, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.   Good morning!  Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for the condition.    In a landmark decision on Thursday, the Food and Drug Administration approved Madrigal Pharmaceuticals ' drug " Rezdiffra ," to be used along with diet and exercise. The company expects the medicine to be available next month with a hefty price tag of $47,400 per year before insurance and other rebates.    So, why is this approval so important?    First of all, people suffering from the disease badly need a treatment. Rezdiffra is specifically approved to treat patients with...
Post a Comment
Read More

How competitive can Roche be in the weight loss drug market?

VIEW IN BROWSER | SUBSCRIBE TUE, SEP 17, 2024 EDITOR'S NOTE     Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon!  Roche is one of several drugmakers hoping to join the booming weight loss drug market, which Novo Nordisk and Eli Lilly are currently dominating. But can the Swiss company develop drugs that can compete with that duopoly?  The answer isn't clear yet.  We need to see more data from longer and larger clinical trials, which will likely take years for Roche to conduct.  But the company last week presented more early-stage data more early-stage data on its experimental obesity injection and pill, which some analysts said raised concerns about how competitive those products can be if they enter the space. Some analysts said the new results showed that both drugs – which Roche acquired through its nearly $3 billion acquisition of Carmot Therapeutics in December – c...
Post a Comment
Read More

Successfully unsubscribed from Markets Morning

Dear Reader, As per your request, you have been removed from our mailing list for Markets Morning Get all the updates from the world of business straight to your inbox Getting bigger and stronger. 4 million+ subscribers MANAGE ALL NEWSLETTERS » Daily Newsletter ...
Post a Comment
Read More